AKT1 and cancer: Mechanistically, this was associated with reduced expression of the ABC efflux protein and inhibition of the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway, a vital cellular signalling pathway that contributes to cell cycle regulation, and increased expression of which is associated with cancer progression and chemotherapy resistance.